ACTRN12615000922572已完成未知
Randomised double-blind, placebo-controlled, cross-over trial to determine the responsiveness of the gut microbiota to a prebiotic supplement in healthy individuals with differing habitual dietary fibre intakes
Genelle Healey0 个研究点目标入组 40 人开始时间: 2015年9月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 19 Years 至 65 Years(—)
- 性别
- All
入选标准
- •The target population for recruitment are healthy male and female individuals between the age of 19 and 65 years with a BMI of between 18.5 and 30kg/m2. Individuals will need to have either a particularly low or high habitual dietary fibre intake to be considered eligible to participate in the study.
排除标准
- •* Aged <19 or >65 years
- •* Taken antibiotics within the last 6 months
- •* Taken laxatives, gastric motility medications, prebiotic or probiotic containing foods or supplements within the last month
- •* Of poor health- cancer, gastrointestinal disorders (irritable bowel syndrome, inflammatory bowel disease, coeliac disease, constipation, diarrhoea, excessive bloating), autoimmune disorders, diabetes, heart disease, renal failure
- •* BMI <18.5 or >30kg/m2
- •* Significant weight loss or weight gain (>5%) within the past year
- •* Significant dietary change within the past year
- •* Pregnant, breastfeeding or planning a pregnancy
- •* Food intolerance which causes gastrointestinal symptoms (i.e. lactose intolerance, gluten sensitivity)
- •* High alcohol consumers
- •If a potential participant is only ineligible to participate in the study because they are taking prebiotic or probiotic containing foods or supplements they can become eligible for inclusion in the study if they are willing to discontinue these foods or supplements for a month prior to starting the study and during the study.
研究者
相似试验
已完成
4 期
Randomised double-blind, placebo-controlled, crossover trial on the effects of modafinil on sleep apnea patients withdrawn from continuous positive airway pressure (cpap) treatmentObstructive sleep apneaRespiratory - Sleep apnoeaACTRN12606000027516Woolcock Institute of Medical Research20
进行中(未招募)
1 期
Randomised double-blind, placebo-controlled, cross-over study comparing the effects of single dose and repeated dosing treatment for 14 days of vestipitant / paroxetine combination in an enriched population of subjects with tinnitus and hearing lossTinnitusEUCTR2006-003295-36-GBGlaxoSmithKline Research & Development Limited
已完成
不适用
Randomized, Placebo-controlled Double-blind Cross-over Study to Evaluate the Effects of Oligofructose on Stool Frequency in Constipated subjectsconstipationNL-OMON40415Ingredion Incorporated120
招募中
2 期
Investigating the effect of synbiotics on uremic toxin concentrations in the pre-dialysis population.Renal and Urogenital - Kidney diseaseDiet and Nutrition - Other diet and nutrition disordersChronic Kidney DiseaseACTRN12613000493741Princess Alexandra Hospital40
进行中(未招募)
1 期
Validation of finger tapping in PD patientsMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2020-000686-16-NLCentre for Human Drug Research20
